OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Building safety into CAR-T therapy
D. Peters, Barbara Savoldo, Natalie S. Grover
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 8
D. Peters, Barbara Savoldo, Natalie S. Grover
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 8
Showing 8 citing articles:
Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 28
Ruiyu Tao, Xiaopeng Han, Xue Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 28
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
Julie K. Jadlowsky, Elizabeth O. Hexner, Amy Marshall, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 5
Julie K. Jadlowsky, Elizabeth O. Hexner, Amy Marshall, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 5
CAR-T cell therapy in AML: recent progress and future perspectives
Shoji Saito, Yozo Nakazawa
International Journal of Hematology (2024) Vol. 120, Iss. 4, pp. 455-466
Closed Access | Times Cited: 6
Shoji Saito, Yozo Nakazawa
International Journal of Hematology (2024) Vol. 120, Iss. 4, pp. 455-466
Closed Access | Times Cited: 6
CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
Yexin Zhou, Shanshan Wei, Meng-Hui Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Yexin Zhou, Shanshan Wei, Meng-Hui Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Therapeutic effects of NK cell-derived EVs on cancer: Current advances and future treatment strategies
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
Small molecule-regulated switches to provide functional control of CAR T cells within the patient
Charlotte U. Zajc, Elise Sylvander, Manfred Lehner, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 425-432
Open Access | Times Cited: 1
Charlotte U. Zajc, Elise Sylvander, Manfred Lehner, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 425-432
Open Access | Times Cited: 1
In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy
Christopher E. Dandoy, J. P. Adams, Andrew Artz, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 10, pp. 942-954
Closed Access | Times Cited: 1
Christopher E. Dandoy, J. P. Adams, Andrew Artz, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 10, pp. 942-954
Closed Access | Times Cited: 1
Bayesian network analysis of risk classification strategies in the regulation of cellular products
Guoshu Jia, Fu Lixia, Likun Wang, et al.
Artificial Intelligence in Medicine (2024) Vol. 155, pp. 102937-102937
Open Access
Guoshu Jia, Fu Lixia, Likun Wang, et al.
Artificial Intelligence in Medicine (2024) Vol. 155, pp. 102937-102937
Open Access
